Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel DiseasesKate D. Lynch, Cynthia Levy, Charlotte Hedin et al.|Clinical Gastroenterology and Hepatology|2019Cited by 104
A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and FunctionLeonie C.S. De Vries, Manon E. Wildenberg, José Duarte et al.|Inflammatory Bowel Diseases|2019Cited by 80
Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitisManon de Krijger, Cyriel Y. Ponsioen, Manon E. Wildenberg et al.|Journal of Hepatology|2019Cited by 41
Characterization of gut-homing molecules in non-endstage livers of patients with primary sclerosing cholangitis and inflammatory bowel diseaseManon de Krijger, Cyriel Y. Ponsioen, Thijmen Visseren et al.|Journal of Translational Autoimmunity|2020Cited by 20
Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel DiseaseAhmed M I Elfiky, Wouter J. de Jonge, Mohammed Ghiboub et al.|Journal of Crohn s and Colitis|2021Cited by 15